CLINICAL_TRIALS
trial_result
· 2025-07-18
Clinical Trial Update: Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese [Phase 2]
Summary
Phase 2 trial evaluating the safety and efficacy of combining bimagrumab with semaglutide in adults who are overweight or obese; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity, Obese | Phase 2 | Status: COMPLETED | Results posted: 2025-07-18